PHARMACOGENETICS OF IRINOTECAN: MINIMISING TOXICITIES AND MAXIMISING CLINICAL RESPONSE

被引：0
|
作者：
Kularatne, B.
Marinaki, A. [1 ]
Spicer, J. [2 ]
Loganayagam, A. [1 ]
Ross, P. [3 ]
机构：
[1] Guys & St Thomas Hosp, Purine Res Lab, London SE1 9RT, England
[2] Kings Coll London, London WC2R 2LS, England
[3] Guys & St Thomas Hosp, Dept Med Oncol, London SE1 9RT, England
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：I35 / I35
页数：1
相关论文
共 50 条
  • [1] Maximising usability and minimising liability - The RESPONSE project
    Stevens, A
    Strang, D
    ADAS: INTERNATIONAL CONFERENCE ON ADVANCED DRIVER ASSISTANCE SYSTEMS, 2001, (483): : 11 - 14
  • [2] Minimising damage, maximising value
    Gonzalez, Juan
    Hydrocarbon Engineering, 2023, 28 (12): : 17 - 21
  • [3] Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping
    Innocenti, Federico
    Ratain, Mark J.
    PHARMACOGENOMICS, 2006, 7 (08) : 1211 - 1221
  • [4] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    Hasegawa, Y
    DRUG METABOLISM REVIEWS, 2005, 37 (03) : 565 - 574
  • [5] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    DRUG METABOLISM REVIEWS, 2004, 36 : 16 - 16
  • [6] K+-selective nanospheres:: maximising response range and minimising response time
    Ruedas-Rama, Maria Jose
    Hall, Elizabeth A. H.
    ANALYST, 2006, 131 (12) : 1282 - 1291
  • [7] Minimising costs and maximising plant efficiency
    Waldow, Dirk
    Waldow, Günter
    Euroheat and Power (English Edition), 2015, 12 (02): : 34 - 35
  • [8] Maximising benefit and minimising harm of screening
    Gray, J. A. Muir
    Patnick, J.
    Blanks, R. G.
    BRITISH MEDICAL JOURNAL, 2008, 336 (7642): : 480 - 483
  • [9] Pharmacogenetics of irinotecan toxicity
    Marsh, S
    McLeod, HL
    PHARMACOGENOMICS, 2004, 5 (07) : 835 - 843
  • [10] Pharmacogenetics and irinotecan therapy
    Kahn, Kristine K.
    Wolff, James J.
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (22) : 2211 - 2217
12345